269 related articles for article (PubMed ID: 15035967)
1. T-cell epitopes in type 1 diabetes.
Panagiotopoulos C; Trudeau JD; Tan R
Curr Diab Rep; 2004 Apr; 4(2):87-94. PubMed ID: 15035967
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
4. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
[TBL] [Abstract][Full Text] [Related]
6. During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities.
DiLorenzo TP; Lieberman SM; Takaki T; Honda S; Chapman HD; Santamaria P; Serreze DV; Nathenson SG
Clin Immunol; 2002 Dec; 105(3):332-41. PubMed ID: 12498815
[TBL] [Abstract][Full Text] [Related]
7. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population.
Amrani A; Verdaguer J; Serra P; Tafuro S; Tan R; Santamaria P
Nature; 2000 Aug; 406(6797):739-42. PubMed ID: 10963600
[TBL] [Abstract][Full Text] [Related]
8. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
[TBL] [Abstract][Full Text] [Related]
9. Interactions of effectors and regulators are decisive in the manifestations of type 1 diabetes in nonobese diabetic mice.
Quinn A; Kumar V; Jensen KP; Sercarz EE
Curr Dir Autoimmun; 2001; 4():171-92. PubMed ID: 11569402
[No Abstract] [Full Text] [Related]
10. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.
Trudeau JD; Kelly-Smith C; Verchere CB; Elliott JF; Dutz JP; Finegood DT; Santamaria P; Tan R
J Clin Invest; 2003 Jan; 111(2):217-23. PubMed ID: 12531877
[TBL] [Abstract][Full Text] [Related]
11. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
12. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
[TBL] [Abstract][Full Text] [Related]
13. CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse.
Kay TW; Chaplin HL; Parker JL; Stephens LA; Thomas HE
Res Immunol; 1997 Jun; 148(5):320-7. PubMed ID: 9352596
[No Abstract] [Full Text] [Related]
14. Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.
Mukherjee G; Chaparro RJ; Schloss J; Smith C; Bando CD; DiLorenzo TP
Immunology; 2015 Apr; 144(4):631-40. PubMed ID: 25333865
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation in the autoimmune diabetes of the NOD mouse.
Unanue ER
Annu Rev Immunol; 2014; 32():579-608. PubMed ID: 24499272
[TBL] [Abstract][Full Text] [Related]
16. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
17. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.
Ferris ST; Carrero JA; Mohan JF; Calderon B; Murphy KM; Unanue ER
Immunity; 2014 Oct; 41(4):657-69. PubMed ID: 25367577
[TBL] [Abstract][Full Text] [Related]
18. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
19. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
[TBL] [Abstract][Full Text] [Related]
20. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes.
Slattery RM; Miller JF; Heath WR; Charlton B
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10808-10. PubMed ID: 7902572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
